Tag: spinraza
Biogen announces new data providing further evidence for SPINRAZA (nusinersen) as...
Biogen today announced new results from the NURTURE study, adding data to the longest study of spinal muscular atrophy (SMA) in pre-symptomatic infants (n=25)....
Biogen scoops sixth Prix Galien award with UK for life-changing rare...
Biogen was announced as the winner of the Orphan Product Award at last night’s UK Prix Galien 2018, for Spinraza, which in 2017 became...
New data show Spinraza beneficial in the treatment of spinal muscular...
Rates of survival are higher, and respiratory intervention rates are lower, in 25 infants with presymptomatic 5q spinal muscular atrophy (SMA) treated with Spinraza...
NICE draft guidance ‘minded no’ for access to Spinraza for SMA...
UK’s National Institute for Health and Care Excellence (NICE) has published its Appraisal Consultation Document (ACD) outlining a ‘minded no’ for the routine funding...